Morrison Foerster has advised Carlsmed. Carlsmed, a commercial-stage medical technology company specializing in AI-enabled personalized spine surgery solutions, has commenced its initial public offering valued at...
Carlsmed Launches $100.5 Million Initial Public Offering
Cofertility’s $7.25 Million Series A Funding Round
Morrison Foerster advised Cofertility on the transaction. Cofertility announced its $7.25 million Series A funding round co-led by Next Ventures and Offline Ventures. Cofertility enables women...